Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1979 1
1981 1
1982 1
1985 2
1986 1
1987 2
1988 2
1989 2
1990 2
1991 3
1992 10
1993 4
1994 5
1995 4
1996 4
1997 11
1998 6
1999 4
2000 4
2001 6
2002 5
2003 11
2004 7
2005 13
2006 13
2007 20
2008 15
2009 18
2010 15
2011 18
2012 32
2013 30
2014 22
2015 24
2016 27
2017 48
2018 45
2019 44
2020 46
2021 56
2022 47
2023 30
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Results by year

Filters applied: . Clear all
Page 1
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Monés J, et al. Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15. Ophthalmology. 2021. PMID: 33207259 Free article. Clinical Trial.
RESULTS: Fifty brolucizumab-treated eyes were considered to have definite/probable drug-related events within the spectrum of IOI, retinal vasculitis, and/or vascular occlusion. On the basis of these cases, incidence of definite/probable IOI was 4.6% (IOI + vasculit …
RESULTS: Fifty brolucizumab-treated eyes were considered to have definite/probable drug-related events within the spectrum of IOI, retina …
Classification Criteria for Behçet Disease Uveitis.
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug;228:80-88. doi: 10.1016/j.ajo.2021.03.058. Epub 2021 May 11. Am J Ophthalmol. 2021. PMID: 33845008 Free PMC article.
Key criteria for Behcet disease uveitis were a diagnosis of Behcet disease using the International Study Group for Behcet Disease criteria and a compatible uveitis, including (1) anterior uveitis; (2) anterior chamber and vitreous inflammation; (3) posterior uveitis with retin …
Key criteria for Behcet disease uveitis were a diagnosis of Behcet disease using the International Study Group for Behcet Disease criteria a …
Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee.
Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, Bielefeld P, Sène D, Kaplanski G, Monnet D, Brézin A, Weber M, Saadoun D, Chiquet C, Kodjikian L. Sève P, et al. Autoimmun Rev. 2017 Dec;16(12):1254-1264. doi: 10.1016/j.autrev.2017.10.010. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037906 Review.
The following groups of patients are not included in these recommendations: children, immunocompromised patients, patients with severe retinal vasculitis, and those with specific eye diseases diagnosed by ophthalmologic examination only. ...
The following groups of patients are not included in these recommendations: children, immunocompromised patients, patients with severe re …
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
The survey included 324 questions related to tubercular anterior uveitis (TAU), tubercular intermediate uveitis (TIU), tubercular panuveitis (TPU), and tubercular retinal vasculitis (TRV) administered by the experts, after which the COTS group met in November 2019 f …
The survey included 324 questions related to tubercular anterior uveitis (TAU), tubercular intermediate uveitis (TIU), tubercular panuveitis …
Vascular abnormalities in uveitis.
Ebrahimiadib N, Maleki A, Fadakar K, Manhapra A, Ghassemi F, Foster CS. Ebrahimiadib N, et al. Surv Ophthalmol. 2021 Jul-Aug;66(4):653-667. doi: 10.1016/j.survophthal.2020.12.006. Epub 2021 Jan 5. Surv Ophthalmol. 2021. PMID: 33412171 Review.
Inflammation can involve several ocular structures, including the sclera, retina, and uvea, and cause vascular changes in these tissues. Although retinal vasculitis is the most common finding associated with uveitis involving the posterior segment, other vascular ab …
Inflammation can involve several ocular structures, including the sclera, retina, and uvea, and cause vascular changes in these tissues. Alt …
Complications of intravitreal injections: 2022.
Patel D, Patel SN, Chaudhary V, Garg SJ. Patel D, et al. Curr Opin Ophthalmol. 2022 May 1;33(3):137-146. doi: 10.1097/ICU.0000000000000850. Epub 2022 Mar 9. Curr Opin Ophthalmol. 2022. PMID: 35266893 Review.
RECENT FINDINGS: Intravitreal vancomycin can cause hemorrhagic occlusive retinal vasculitis resulting in severe vision loss. Intravitreal brolucizumab is associated with intraocular inflammation and retinal vasculitis resulting in significant vision lo …
RECENT FINDINGS: Intravitreal vancomycin can cause hemorrhagic occlusive retinal vasculitis resulting in severe vision loss. I …
Electroretinographic findings in retinal vasculitis.
Ghoraba HH, Matsumiya W, Or C, Khojasteh H, Patel P, Karaca I, Regenold J, Zaidi M, Hwang J, Lajevardi S, Yavari N, Than NTT, Park SW, Akhavanrezayat A, Uludag G, Yasar C, Leung LB, Nguyen QD. Ghoraba HH, et al. Br J Ophthalmol. 2023 Nov 22;107(12):1834-1838. doi: 10.1136/bjo-2022-321716. Br J Ophthalmol. 2023. PMID: 36130816 Free PMC article.
AIM: To describe and correlate electroretinographic responses with clinical and angiographic findings in retinal vasculitis (RV). METHODS: Medical records of patients with diagnosis of RV at a tertiary eye centre from December 2017 to May 2021 were reviewed. ...
AIM: To describe and correlate electroretinographic responses with clinical and angiographic findings in retinal vasculitis (R …
Retinal vasculitis.
Walton RC, Ashmore ED. Walton RC, et al. Curr Opin Ophthalmol. 2003 Dec;14(6):413-9. doi: 10.1097/00055735-200312000-00015. Curr Opin Ophthalmol. 2003. PMID: 14615648 Review.
Retinal vasculitis represents a group of diseases characterized by inflammation affecting the retinal vasculature. ...The management of infectious causes of retinal vasculitis consists of antimicrobial therapy while noninfectious retinal vasc …
Retinal vasculitis represents a group of diseases characterized by inflammation affecting the retinal vasculature. ...The mana …
Demyelinating plaque-associated uveitis.
Hedayatfar A, Anvari P, Herbort CP Jr, Chee SP. Hedayatfar A, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):575-582. doi: 10.1007/s00417-023-06270-3. Epub 2023 Oct 19. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37855958
New imaging techniques in retinal vasculitis.
Mesquida M, Llorens V, Adán A. Mesquida M, et al. Med Clin (Barc). 2017 Sep 20;149(6):261-266. doi: 10.1016/j.medcli.2017.05.009. Epub 2017 Jul 5. Med Clin (Barc). 2017. PMID: 28687121 Review. English, Spanish.
The term retinal vasculitis (RV) encompasses a heterogeneous group of sight-threatening conditions that are included in the intraocular inflammatory diseases that affect the posterior segment of the eye. ...
The term retinal vasculitis (RV) encompasses a heterogeneous group of sight-threatening conditions that are included in the in …
545 results